# OptimizeRx Corp: Form 8-K, filed May 12, 2026

- Company: [OptimizeRx Corp](/companies/oprx.md) (CIK 1448431)
- Form: 8-K
- Filed: 2026-05-12
- Accepted by EDGAR: May 12, 2026, 20:07 ET
- Period: 2026-05-12
- Accession: 0001448431-26-000009
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000009/oprx-20260512.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1448431/000144843126000009/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.02: Results of operations
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1448431/000144843126000009/oprx-20260512.htm

Filed May 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001448431-26-000009. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.